Literature DB >> 19514831

The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review.

Linda Vona-Davis1, David P Rose.   

Abstract

OBJECTIVE: Socioeconomic deprivation is associated with an increased risk of breast cancer mortality. This article summarizes the relationships between socioeconomic status (SES) and breast cancer in white European women compared with racial and ethnic groups in the United States. Furthermore, we examine the association between obesity and breast cancer within socioeconomic disparities.
METHODS: Mortality rates were published by the American Cancer Society and the National Cancer Institute Surveillance, Epidemiology, and End Results Program. Obesity data were derived from the National Center for Health Statistics Behavioral Risk Factor Surveillance System. MEDLINE searches were performed using keywords, such as socioeconomic status, poverty, African American, Hispanic, race, and combined with related articles.
RESULTS: Socioeconomic deprivation may be responsible for the increased risk of breast cancer mortality in African American and Hispanic patients, as they are more likely than white American patients to be diagnosed with advanced disease. Among white women, social deprivation is related to poor breast cancer prognosis, with increased prevalence rates of high-grade, estrogen receptor (ER)-negative tumors, similar to that of triple-negative breast cancers observed in African American and Hispanic women. Obesity is associated with advanced breast cancer at diagnosis, high tumor proliferation rates, and more triple-negative phenotypes, indicating that it may adversely contribute to prognosis.
CONCLUSIONS: Most studies show an effect of SES on breast cancer incidence and prognosis. Research should focus on the influence of social deprivation on breast cancer characteristics, such as absence of ER expression, that occurs in African Americans and Hispanics and in white European women with a different genetic background.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19514831     DOI: 10.1089/jwh.2008.1127

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  96 in total

Review 1.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

Review 2.  A review of cancer in U.S. Hispanic populations.

Authors:  Robert W Haile; Esther M John; A Joan Levine; Victoria K Cortessis; Jennifer B Unger; Melissa Gonzales; Elad Ziv; Patricia Thompson; Donna Spruijt-Metz; Katherine L Tucker; Jonine L Bernstein; Thomas E Rohan; Gloria Y F Ho; Melissa L Bondy; Maria Elena Martinez; Linda Cook; Mariana C Stern; Marcia Cruz Correa; Jonelle Wright; Seth J Schwartz; Lourdes Baezconde-Garbanati; Victoria Blinder; Patricia Miranda; Richard Hayes; George Friedman-Jiménez; Kristine R Monroe; Christopher A Haiman; Brian E Henderson; Duncan C Thomas; Paolo Boffetta
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

3.  The role of early-life socioeconomic status in breast cancer incidence and mortality: unraveling life course mechanisms.

Authors:  Tetyana Pudrovska; Benedicta Anikputa
Journal:  J Aging Health       Date:  2011-09-28

4.  A comparison of breast and cervical cancer legislation and screening in Georgia, North Carolina, and South Carolina.

Authors:  Stephanie Miles-Richardson; Daniel Blumenthal; Ernest Alema-Mensah
Journal:  J Health Care Poor Underserved       Date:  2012-05

5.  Disparities in breast cancer characteristics and outcomes by race/ethnicity.

Authors:  Siew Loon Ooi; Maria Elena Martinez; Christopher I Li
Journal:  Breast Cancer Res Treat       Date:  2010-10-07       Impact factor: 4.872

6.  Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women.

Authors:  Kathryn E Weaver; Fabian Camacho; Wenke Hwang; Roger Anderson; Gretchen Kimmick
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

Review 7.  Population and target considerations for triple-negative breast cancer clinical trials.

Authors:  Terry Hyslop; Yvonne Michael; Tiffany Avery; Hallgeir Rui
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

Review 8.  Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.

Authors:  Sachin Kumar Deshmukh; Sanjeev K Srivastava; Nikhil Tyagi; Aamir Ahmad; Ajay P Singh; Ahmed A L Ghadhban; Donna L Dyess; James E Carter; Kari Dugger; Seema Singh
Journal:  Carcinogenesis       Date:  2017-08-01       Impact factor: 4.944

9.  Factors influencing breast cancer screening in low-income African Americans in Tennessee.

Authors:  Kushal Patel; Mohamed Kanu; Jianguo Liu; Brea Bond; Elizabeth Brown; Elizabeth Williams; Rosemary Theriot; Stephanie Bailey; Maureen Sanderson; Margaret Hargreaves
Journal:  J Community Health       Date:  2014-10

10.  Temporal trends in area socioeconomic disparities in breast-cancer incidence and mortality, 1988-2005.

Authors:  Mario Schootman; Min Lian; Anjali D Deshpande; Elizabeth A Baker; Sandi L Pruitt; Rebecca Aft; Donna B Jeffe
Journal:  Breast Cancer Res Treat       Date:  2010-01-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.